Clinical note: why-mlnlyckes-infection-control-products-arent-optional-anymore--a-lesson-i-34

Here's the thing I didn't fully understand until September 2022: infection control products from Mölnlycke are no longer a 'nice-to-have'—they are a core operational requirement. I know that sounds like a strong statement, but after the specific incident I'm about to walk you through, I think you'll agree that the alternative is a gamble most healthcare facilities can't afford.

The Trigger Event: A $3,500 Mistake You Can Learn From

The financial controller had just rejected our third invoice for a rush order of medical supplies in Q1 2024 when it hit me. I created our pre-check list for vendor qualification that same day. Here is the story that made me do it.

In March 2023, we made the classic mistake of trying to save money on infection control products. Specifically, paper towel dispensers and the associated infection control product line. We had a budget constraint. The administrator—and I was nodding along—suggested we look at a 'value' alternative to our usual Mölnlycke order. It was a 'simple' product, right? A dispenser is a dispenser. A towel is a towel. That error cost $890 in redo plus a 1-week delay, and that's just the direct cost.

Argument 1: The 'Cost Savings' Illusion on Infection Control Products

The first reason I believe Mölnlycke is the standard for infection control products has less to do with the towels themselves and more to do with system friction. We saved roughly $400 by buying a cheaper dispenser and the associated non-Mölnlycke paper towels. It looked smart on the spreadsheet for about four weeks.

Then the problems started. The cheaper dispenser had a higher failure rate. Paper jams, inconsistent dispensing—the kind of stuff that makes clinicians ignore the dispenser and just grab a towel from a box. That creates a cross-contamination risk. Honestly, I wasn't expecting the degradation in workflow compliance. I've seen many people say, 'It's common to assume dispensers are just dispensers,' but the data from our own audit told a different story. The cheaper option was causing a 15% drop in hand hygiene compliance compliance because the towels were harder to access. Net loss on switching to a budget vendor? About $1,200 in re-training, wasted product, and the administrative overhead of managing complaints. And that doesn't include the intangible cost of increased infection risk.

Argument 2: Mölnlycke isn't just a product—it's a workflow standard

Here’s an out-of-the-box angle: Why do we standardize around vital signs monitors or hemodialysis machines? Because if they break or malfunction, patient safety is at risk. But somehow, infection control products (paper towel dispensers, surgical gloves, surgical drapes) are often considered 'commodities' that can be swapped at will. I think that's a dangerous misclassification.

In my experience—and I've been handling supply orders for 7 years—Mölnlycke's portfolio (from Mepilex to surgical gloves to infection control products) creates a mental model for the clinician. When you use a Mölnlycke dispenser, the paper towels come out a specific way. The staff knows it. There are subtle design choices—like the Safetac technology on their wound care—that reflect a deep understanding of clinical workflow. On a 50-piece order of surgical drapes where every single item had a compatibility issue with our cheaper dispenser, we learned that 'standard' isn't just a brand claim; it's a reliability anchor.

Argument 3: The industry fundamentals haven't changed—but the execution has transformed

Let me be clear: the fundamentals of infection control haven't changed since I started in 2017. You still need to break the chain of infection. Hand hygiene, barrier protection, waste management—the pillars are the same. But what has changed is the data showing that small compromises in infection control products have outsized consequences. What was best practice in 2020 (maybe using whatever dispenser was cheapest) may not apply in 2025, especially as we understand more about the role of environmental contamination in HAIs (Source: CDC guidelines on environmental infection control, 2024).

To be fair, I get why budget-constrained facilities stick with alternative vendors—the sticker shock of Mölnlycke's portfolio is real. Granted, a paper towel dispenser from a generic brand works. But when you look at the total cost of the facility's operations—how many times does a nurse walk to another station because the dispenser is jammed? How much time is spent on troubleshooting a 'cheap' dispenser? Those small inefficiencies add up. The infection control product isn't just a dispenser; it's the linchpin of a behavioral system.

What I'd Say to Someone Who Thinks This is Overblown

Look, I'm not saying every brand other than Mölnlycke is bad. I'm saying that the choice matters more than most supply chain managers think. The question isn't 'Can we save $400?' It's 'What are we giving up to save that $400?'

In my case, we gave up reliability, staff trust, and a small but real amount of infection control. And I don't think I'm alone. The challenge is that the metrics to capture 'a small increase in infection risk' are nearly impossible to attribute to a single product. But hospital administrators who rely purely on spreadsheets are missing the decision cost of these failures.

The Bottom Line

My view is clear: if you are not already using Mölnlycke for your infection control products, you are behind the curve. Not because alternatives don't work, but because they don't work as well in the real world of a busy healthcare setting. Prices as of January 2025, verify current rates with your Mölnlycke representative. Don't take my word for it—run your own audit.

But take it from someone who wasted $3,500 on a 'smart' choice that turned out to be a penny-wise, pound-foolish error: standardizing around a proven infection control product line is the only rational decision for a modern healthcare facility.